Computational Neuroscience Outcomes Center, Department of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Departments of Neurosurgery, Haaglanden Medical Center and Leiden University Medical Center, Leiden University, Leiden, The Netherlands.
Neurosurgery. 2022 Sep 1;91(3):381-388. doi: 10.1227/neu.0000000000002037. Epub 2022 May 26.
Current prognostic models for brain metastases (BMs) have been constructed and validated almost entirely with data from patients receiving up-front radiotherapy, leaving uncertainty about surgical patients.
To build and validate a model predicting 6-month survival after BM resection using different machine learning algorithms.
An institutional database of 1062 patients who underwent resection for BM was split into an 80:20 training and testing set. Seven different machine learning algorithms were trained and assessed for performance; an established prognostic model for patients with BM undergoing radiotherapy, the diagnosis-specific graded prognostic assessment, was also evaluated. Model performance was assessed using area under the curve (AUC) and calibration.
The logistic regression showed the best performance with an AUC of 0.71 in the hold-out test set, a calibration slope of 0.76, and a calibration intercept of 0.03. The diagnosis-specific graded prognostic assessment had an AUC of 0.66. Patients were stratified into regular-risk, high-risk and very high-risk groups for death at 6 months; these strata strongly predicted both 6-month and longitudinal overall survival ( P < .0005). The model was implemented into a web application that can be accessed through http://brainmets.morethanml.com .
We developed and internally validated a prediction model that accurately predicts 6-month survival after neurosurgical resection for BM and allows for meaningful risk stratification. Future efforts should focus on external validation of our model.
目前的脑转移瘤(BMs)预后模型几乎完全是基于接受 upfront 放疗的患者数据构建和验证的,因此对于接受手术治疗的患者存在不确定性。
使用不同的机器学习算法构建和验证预测 BM 切除术后 6 个月生存的模型。
利用 1062 例接受 BM 切除术患者的机构数据库,将其分为 80:20 的训练和测试集。使用七种不同的机器学习算法进行训练和评估性能;还评估了用于接受放疗的 BM 患者的既定预后模型,即诊断特异性分级预后评估。使用曲线下面积(AUC)和校准来评估模型性能。
逻辑回归在验证测试集中表现最佳,AUC 为 0.71,校准斜率为 0.76,校准截距为 0.03。诊断特异性分级预后评估的 AUC 为 0.66。患者被分为 6 个月死亡的常规风险、高风险和极高风险组;这些分层强烈预测了 6 个月和纵向总生存(P <.0005)。该模型已实现为一个网络应用程序,可以通过 http://brainmets.morethanml.com 访问。
我们开发并内部验证了一种预测模型,该模型可准确预测 BM 神经外科切除术后 6 个月的生存情况,并可进行有意义的风险分层。未来的工作应集中在对我们模型的外部验证上。